(Q57225579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

0 references

0 references

P Rüegsegger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

A Keller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M A Dambacher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

language of work or name

English

0 references

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

30-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis

24 October 2019

cites work

1 reference

12 December 2020

Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis

1 reference

12 December 2020

Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study

1 reference

12 December 2020

Habitual dietary calcium intake and cortical bone loss in perimenopausal women: a longitudinal study

1 reference

12 December 2020

[Intestinal absorption of calcium gluconate and oseine-mineral complex: an evaluation by conventional analyses]

1 reference

12 December 2020

Spinal bone loss and ovulatory disturbances

1 reference

12 December 2020

Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents

1 reference

12 December 2020

Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women.

1 reference

12 December 2020

Calcium absorption from a new calcium delivery system (CCM)

1 reference

12 December 2020

Postmenopausal bone density and milk consumption in childhood and adolescence

1 reference

12 December 2020

Differential effects of aging and disease on trabecular and compact bone density of the radius

1 reference

12 December 2020

Quantitative computed tomography at peripheral measuring sites

1 reference

12 December 2020

Calcium intake and bone mass: a quantitative review of the evidence

1 reference

12 December 2020

Gastrointestinal absorption of calcium from milk and calcium salts.

1 reference

12 December 2020

The influence of ossein-hydroxyapatite compound ('Ossopan') on the healing of a bone defect

1 reference

12 December 2020

Bone loss in premenopausal and postmenopausal women. A cross-sectional and longitudinal study using quantitative computed tomography

1 reference

12 December 2020

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

12 December 2020

Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy

1 reference

12 December 2020

Quantitation of growth factors in ossein-mineral-compound

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01623655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7703621%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference